These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18676690)

  • 1. Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.
    Ebrahimian T; Sairam MR; Schiffrin EL; Touyz RM
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1481-8. PubMed ID: 18676690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
    Javeshghani D; Touyz RM; Sairam MR; Virdis A; Neves MF; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):761-7. PubMed ID: 12885794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
    Sriramula S; Francis J
    PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
    Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local angiotensin II aggravates cardiac remodeling in hypertension.
    Xu J; Carretero OA; Liao TD; Peng H; Shesely EG; Xu J; Liu TS; Yang JJ; Reudelhuber TL; Yang XP
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1328-38. PubMed ID: 20833959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension.
    Antunes TT; Callera GE; He Y; Yogi A; Ryazanov AG; Ryazanova LV; Zhai A; Stewart DJ; Shrier A; Touyz RM
    Hypertension; 2016 Apr; 67(4):763-73. PubMed ID: 26928801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II-Induced Hypertension.
    Callera GE; Antunes TT; He Y; Montezano AC; Yogi A; Savoia C; Touyz RM
    Hypertension; 2016 Nov; 68(5):1179-1190. PubMed ID: 27620391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.
    Ikeda Y; Aihara K; Sato T; Akaike M; Yoshizumi M; Suzaki Y; Izawa Y; Fujimura M; Hashizume S; Kato M; Yagi S; Tamaki T; Kawano H; Matsumoto T; Azuma H; Kato S; Matsumoto T
    J Biol Chem; 2005 Aug; 280(33):29661-6. PubMed ID: 15961403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension.
    Diep QN; El Mabrouk M; Yue P; Schiffrin EL
    Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1635-41. PubMed ID: 11959625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
    Grobe JL; Mecca AP; Lingis M; Shenoy V; Bolton TA; Machado JM; Speth RC; Raizada MK; Katovich MJ
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H736-42. PubMed ID: 17098828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.